GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Int'l Group Co Ltd (SZSE:000411) » Definitions » Research & Development

Zhejiang Int'l Group Co (SZSE:000411) Research & Development : ¥9 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Zhejiang Int'l Group Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zhejiang Int'l Group Co's Research & Development for the three months ended in Mar. 2024 was ¥2 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥9 Mil.


Zhejiang Int'l Group Co Research & Development Historical Data

The historical data trend for Zhejiang Int'l Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Int'l Group Co Research & Development Chart

Zhejiang Int'l Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.96 2.02 8.56 12.93 8.83

Zhejiang Int'l Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 2.19 2.04 2.74 2.01

Zhejiang Int'l Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Int'l Group Co  (SZSE:000411) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Zhejiang Int'l Group Co Research & Development Related Terms

Thank you for viewing the detailed overview of Zhejiang Int'l Group Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Int'l Group Co (SZSE:000411) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Jiangnan Lane, Dongxin Road, Building 3, Xiacheng District, Zhejiang Province, Hangzhou, CHN
Zhejiang Int'l Group Co Ltd is a China-based company operating in three major businesses: drugs, traditional Chinese medicine, and biological equipment.
Executives
Luo Guo Liang Executives
Zhang Yi Ming Executives
Zhao Pei Hong Executives
Wang Jiang Wei Executives
Ying Xu Jie Executives
Bao Zhi Hu Directors, executives
Wu Min Ying Supervisors
Jiang Ju Fang Directors, executives
Zhang Bao Hong Director
Wu Xiu Dong Executives
Qian Yong Lin Director
Zheng Yu Ming Director

Zhejiang Int'l Group Co (SZSE:000411) Headlines

No Headlines